Our mission is to help our clients and partners translate their discovery biology output into preclinical candidates that have better chances of becoming marketed medicines in the least amount of time possible. We offer services in Lead Generation, Lead Optimization and early ADMET/PK studies.
NiKem Research Srl receives the approval from the French Ministry of Research as a “Crédit d’Impôt Recherche” (C.I.R.) Certified Company (August 4th, 2008) Click here to learn more »

Imagine that. Decades of pharmaceutical drug discovery experience know-how and a state of the art facility becoming all of a sudden available on an outsourcing basis. Well, that was 7 years ago, and a lot has changed.
Today NiKem is more than tripled in size, has expanded and improved their state of the art facility, and has helped a portfolio of very satisfied clients advance their pipelines out of discovery and into the clinic.
To learn more about how NiKem can help your company advance its pipeline, click here »